About Formation Bio
Formation Bio is a Healthcare company based in New York (United States) founded in 2016 by Benjamine Liu and Linhao Zhang. It operates in the Healthcare and Technology sectors. Formation Bio has raised $608.25 million across 4 funding rounds from investors including Sanofi, Maven Capital Partners and Spark Capital. The company has 197 employees. Formation Bio was last valued at $1.7 billion in December 2025. Its chief executive, as recorded, is Benjamine Liu. Its website formation.bio draws about 16 thousand monthly visits. Formation Bio offers products and services including Drug Development Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its competitors include Incyte, Flexion Therapeutics and AbSci; 2 of its 3 listed competitors have raised funding.
Company details
AI-powered drug discovery platform for various diseases. The company leverages technology such as LLMs and the modern data stack in novel ways to efficiently design and operate clinical development in Atopic Dermatitis, Chronic Hand Eczema, and Knee Osteoarthritis.
- Headquarters New York, United States
- Employees 197
- Founders Benjamine Liu, Linhao Zhang
- Stage Unicorn
- SectorsHealthcareTechnology
- Website formation.bio
- Social LinkedIn X
- Total Equity Funding$608.25M (USD)
in 4 rounds
- Latest Funding Round$372M (USD), Series D
May 2024
- InvestorsSanofi
& 18 more
- Employee Count197
Products & Services of Formation Bio
Formation Bio offers a comprehensive portfolio of products and services, including Drug Development Platform.
Accelerates drug development using AI for efficient clinical trials
Funding Insights of Formation Bio
Formation Bio has successfully raised a total of $608.25M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $372 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $608.25M
- Total Rounds 4
- Last Round Series D — $372M
- Investors Count 19
All 4 funding rounds of Formation Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $372M | Series D | – | a16z | |
| Sep 2021 | $156M | Series C | – | – | |
| Jun 2018 | $80M | Series B | – | – | |
| Jun 2017 | Series A | – | Sequoia Capital | – |
| Date | Valuation | Stage |
|---|
Full valuation and stage history of Formation Bio
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $1.7B (Dec 2025). 19 investors in total: 17 institutional and 2 angel.
Investors in Formation Bio
Formation Bio has secured backing from 19 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Sanofi, Maven Capital Partners and Spark Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in technology sectors are handled by Andreessen Horowitz. | a16z.com | |||
Philanthropic assets are managed by Willett Advisors LLC. | willettadvisors.com | New York, United States | ||
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
Early-stage technology startups are invested in by Thrive Capital. | thrivecap.com | New York, United States | ||
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Investments in technology startups are made by Felicis Ventures. | felicis.com | Menlo Park, United States | ||
Private equity investments are made in technology-enabled growth companies. | dragoneer.com | San Francisco, United States | ||
Venture capital firm focused on multiple sectors | soundventures.com | |||
Tech startups are funded by S32, a venture capital entity. | s32.com | Sunnyvale, United States | ||
Early-stage investments are provided to transformative technology companies. | svangel.com | San Francisco, United States |
Investor details for Formation Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Formation Bio
51 people are tracked at Formation Bio (22 in leadership, 6 in board & advisors, 23 in team); the tracked headcount is 197.
| Name | Role | Group |
|---|---|---|
Benjamine Liu | Co-Founder & CEO | Leadership |
Linhao Zhang | Co-Founder | Leadership |
Ben Liu | CEO & Co-Founder | Leadership |
Erin Siegel Faynleyb | Director, People Business Partner | Leadership |
Enrique García-Rivera | Senior Director, Data Science | Leadership |
Jennifer Kang | Senior Director, Program Management | Leadership |
Emma Nealon | Director, Investments & Business Development | Leadership |
Melanie Hullings | Director, Clinical Data Analytics & Programming | Leadership |
Gavin Corcoran | Chief Development Officer | Leadership |
James Leslie | CFO | Leadership |
David Marchman | Director, People Engagement | Leadership |
Maya Dongier | Director Of Accounting | Leadership |
Silvina Garcia Rubio | Vp, CMC | Leadership |
Dale Levine Klasko | Vice President, People | Leadership |
Sandeep Basnet | Senior Director, Clinical Development | Leadership |
Nirav Patel | Associate Director, Clinical Development | Leadership |
Sunitha Rao | Director Of Engineering | Leadership |
Debra Wallace | Director, Drug Substance Development | Leadership |
Wenjun | Sr. Director, Head Of Statistical Programming | Leadership |
Wah Yan | Director Of Business Development | Leadership |
31 more people are available in the full profile.
Complete people profiles for Formation Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Formation Bio
4 dated milestones of Formation Bio across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Formation Bio is founded.
- Funding First funding round.
- Milestone Reaches Unicorn status.
- Funding Latest funding round, Series D, of $372.0M.
Competitors of Formation Bio
Formation Bio has 3 listed competitors in our database, 2 of them funded. They include Incyte, Flexion Therapeutics and AbSci.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| incyte.com | 1991 | Wilmington, United States | 1,387 | Small molecules are developed for cancer and skin disease treatments. | ||
| flexiontherapeutics.com | 2007 | Woburn, United States | $62M | 692 | Developer of therapies for the treatment of musculoskeletal disorders | |
| absci.com | 2011 | Vancouver, United States | $227.56M | 256 | AI-based technology is used for recombinant protein production in therapeutics. |
Detailed competitors of Formation Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Formation Bio
The website of Formation Bio (formation.bio) receives about 15.9K visits a month.
- Monthly visits15.9K
▲ 19.3% vs previous month
Websites whose visitors overlap most with Formation Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jobs.ashbyhq.com | jobs.ashbyhq.com | 100% | #4,138 | – | |
jobs.lever.co | jobs.lever.co | 67% | #4,880 | – | |
| karkidi.com | 54% | 20.4K | #1,340,105 | View details | |
| glassdoor.com | 41% | 30.5M | #1,976 | View details |
Top companies in Orthopedics
3 companies that operate in the same segment as Formation Bio (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Formation Bio
Complete news archive for Formation Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Formation Bio
Formation Bio was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Formation Bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Benjamine Liu is the CEO of Formation Bio, as recorded in our data. They have also founded this company.
Formation Bio is a funded company, having raised a total of $608.25M across 4 funding rounds to date.
Formation Bio has 197 employees.
AI-powered drug discovery platform for various diseases. The company leverages technology such as LLMs and the modern data stack in novel ways to efficiently design and operate clinical development in Atopic Dermatitis, Chronic Hand Eczema, and Knee Osteoarthritis.
Formation Bio's top competitors include Flexion Therapeutics, Incyte and AbSci.
Formation Bio offers Drug Development Platform.
Formation Bio has 19 investors. Key investors include Sanofi, Maven Capital Partners, Spark Capital, ArrowMark Partners, and Andreessen Horowitz.
The valuation of Formation Bio is $1.7B as of Dec 2025.